- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Marconi lists its stock on NASDAQ
Global communications company Marconi is now listed on the NASDAQ stock exchange (MONI) in an effort to raise the firm's North American profile.International companies often find recruiting in the U.S. easier when domestic stock options can be provided
Global communications company Marconi is now listed on the NASDAQ stock exchange (MONI) in an effort to raise the firm's North American profile.
International companies often find recruiting in the U.S. easier when domestic stock options can be provided employees.
The U.K.-based firm, with some 49,000 employees worldwide, has previously been listed only on the London Exchange (also MONI). It describes itself as a company that specializes in "broadband infrastructure solutions
to telecommunications service providers and enterprises worldwide."
In the U.S., the firm's main presence is Marconi Medical Systems (formerly Picker International), headquartered in Cleveland, where it has 3500 employees.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
